Dominic W. Lai, M.D., is VP, Clinical Development at Acrivon Therapeutics, Inc. After finishing his medical training, he worked for a private medical oncology clinic before joining the pharmaceutical industry in 2013. Since 2013, with increasing levels of responsibilities, he has worked at various companies including Astra Zeneca, AbbVie, Arcus Biosciences, and Seagen. His industry experience includes being a clinical development leader for multiple cancer immunotherapies and antibody drug conjugates and a global registrational Phase 3 trial in bladder cancer. Dominic received his M.D. from Albert Einstein College of Medicine. He trained in internal medicine at the West Los Angeles Veterans Administration Medical Center and trained in hematology and medical oncology at the New York University Langone Medical Center.